维康药业
(300878)
| 流通市值：40.43亿 | | | 总市值：40.61亿 |
| 流通股本：1.44亿 | | | 总股本：1.45亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 263,080,649.55 | 272,998,138.15 | 260,159,620.72 | 253,961,470.43 |
| 交易性金融资产 | 10,000,000 | 10,000,000 | 5,000,000 | - |
| 应收票据及应收账款 | 108,606,185.82 | 113,962,905.85 | 144,595,255.91 | 137,560,582.54 |
| 应收账款 | 108,606,185.82 | 113,962,905.85 | 144,595,255.91 | 137,560,582.54 |
| 应收款项融资 | 23,814,789.36 | 21,111,712.28 | 22,653,936.68 | 28,154,269.28 |
| 预付款项 | 5,180,424.55 | 1,960,945.91 | 3,018,158.36 | 2,772,229.58 |
| 其他应收款合计 | 14,917,425.03 | 13,527,455.6 | 14,868,822.67 | 52,152,930.85 |
| 存货 | 83,555,057.67 | 108,072,791.68 | 137,159,930.93 | 118,324,926.38 |
| 其他流动资产 | 23,859,474 | 27,701,615.92 | 23,338,303.81 | 23,555,873.05 |
| 流动资产合计 | 533,014,005.98 | 569,335,565.39 | 610,794,029.08 | 616,482,282.11 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 25,000,000 | 25,000,000 | 25,000,000 | 25,000,000 |
| 投资性房地产 | 19,030,563.8 | 22,059,611.11 | 22,211,724.55 | 22,363,838 |
| 固定资产 | 756,857,717.25 | 770,263,047.08 | 785,423,030.1 | 791,607,495.03 |
| 在建工程 | 57,799,756.06 | 58,662,829.13 | 61,840,750.9 | 55,098,016.45 |
| 使用权资产 | 5,106,109.29 | 5,723,175.34 | 6,340,241.38 | 6,957,307.42 |
| 无形资产 | 32,257,131.15 | 32,701,640.23 | 33,146,819.18 | 33,591,998.14 |
| 商誉 | 10,894,160.95 | 10,917,833.64 | 10,941,506.32 | 10,965,179.01 |
| 长期待摊费用 | 3,489,217.48 | 2,484,315.62 | 2,732,747.09 | 2,514,604.36 |
| 递延所得税资产 | 43,564,630.45 | 47,838,743.2 | 47,228,931.8 | 54,665,466.64 |
| 其他非流动资产 | 990,000 | 990,000 | 32,990,000 | 33,076,852.4 |
| 非流动资产合计 | 954,989,286.43 | 976,641,195.35 | 1,027,855,751.32 | 1,035,840,757.45 |
| 资产总计 | 1,488,003,292.41 | 1,545,976,760.74 | 1,638,649,780.4 | 1,652,323,039.56 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 10,008,861.11 |
| 应付票据及应付账款 | 65,692,233.74 | 70,741,767.23 | 87,009,956.1 | 78,853,866.72 |
| 其中：应付票据 | - | - | - | 601,825.64 |
| 应付账款 | 65,692,233.74 | 70,741,767.23 | 87,009,956.1 | 78,252,041.08 |
| 预收款项 | 110,851.08 | 211,231.41 | 138,324.5 | 497,761.97 |
| 合同负债 | 20,782,616.87 | 14,012,336.56 | 9,673,708 | 10,681,828.81 |
| 应付职工薪酬 | 5,584,548.05 | 4,439,803.7 | 3,819,477.73 | 8,139,522.56 |
| 应交税费 | 17,512,714.26 | 15,720,400.37 | 14,223,696.25 | 20,349,825.79 |
| 其他应付款合计 | 24,847,248.57 | 25,307,694.45 | 21,210,015.65 | 19,702,778.21 |
| 一年内到期的非流动负债 | 90,775,071.12 | 90,250,071.12 | 90,759,627.83 | 90,759,627.83 |
| 其他流动负债 | 2,701,307.24 | 1,821,170.8 | 1,257,085.94 | 1,387,472.98 |
| 流动负债合计 | 228,006,590.93 | 222,504,475.64 | 228,091,892 | 240,381,545.98 |
| 非流动负债: | | | | |
| 长期借款 | 182,120,952.19 | 182,120,952.19 | 197,372,877.74 | 186,619,205.86 |
| 租赁负债 | 3,076,665.42 | 4,478,534.19 | 4,313,220.7 | 5,178,925.04 |
| 递延收益 | 37,841,969.67 | 40,377,542.53 | 37,861,115.39 | 38,922,688.25 |
| 递延所得税负债 | 7,324,645.44 | 7,348,318.13 | 7,371,990.81 | 7,395,663.5 |
| 非流动负债合计 | 230,364,232.72 | 234,325,347.04 | 246,919,204.64 | 238,116,482.65 |
| 负债合计 | 458,370,823.65 | 456,829,822.68 | 475,011,096.64 | 478,498,028.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 144,790,322 | 144,790,322 | 144,790,322 | 144,790,322 |
| 资本公积 | 680,767,826.97 | 680,767,826.97 | 680,767,826.97 | 680,767,826.97 |
| 减:库存股 | 49,998,351.8 | 49,998,351.8 | 49,998,351.8 | 49,998,351.8 |
| 盈余公积 | 65,194,788.4 | 65,194,788.4 | 65,194,788.4 | 65,194,788.4 |
| 未分配利润 | 173,170,380.83 | 232,805,291.59 | 307,057,315.8 | 316,911,974.14 |
| 归属于母公司股东权益合计 | 1,013,924,966.4 | 1,073,559,877.16 | 1,147,811,901.37 | 1,157,666,559.71 |
| 少数股东权益 | 15,707,502.36 | 15,587,060.9 | 15,826,782.39 | 16,158,451.22 |
| 股东权益合计 | 1,029,632,468.76 | 1,089,146,938.06 | 1,163,638,683.76 | 1,173,825,010.93 |
| 负债和股东权益合计 | 1,488,003,292.41 | 1,545,976,760.74 | 1,638,649,780.4 | 1,652,323,039.56 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 保留意见 |